Biomind Labs Announces Listing on the Canadian Securities Exchange and the Delisting From the Cboe Canada
Biomind Labs Applauds Landmark Executive Order Accelerating Psychedelic Research and Access in The United States
Heliostar Presents Q2 2026 Financial and Operating Results with Record Gold Production and Cash Balance
